“A proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding protein”.J. Biol. Chem.277(43): 40362–7.(October 2002).doi:10.1074/jbc.M206194200.PMID12171929.
“Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation”.Genes Dev.7(8): 1572–83.(August 1993).doi:10.1101/gad.7.8.1572.PMID8101826.
“DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci”.Nat. Genet.25(3): 269–77.(July 2000).doi:10.1038/77023.PMID10888872.
“Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation”.Oncogene22(28): 4301–13.(July 2003).doi:10.1038/sj.onc.1206606.PMID12853968.
“Regulation of human flap endonuclease-1 activity by acetylation through the transcriptional coactivator p300”.Mol. Cell7(6): 1221–31.(June 2001).doi:10.1016/s1097-2765(01)00272-6.PMID11430825.
“The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA-binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21”.J. Biol. Chem.272(39): 24522–9.(September 1997).doi:10.1074/jbc.272.39.24522.PMID9305916.
“Interaction of human AP endonuclease 1 with flap endonuclease 1 and proliferating cell nuclear antigen involved in long-patch base excision repair”.Biochemistry40(42): 12639–44.(October 2001).doi:10.1021/bi011117i.PMID11601988.
“p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues”.Oncogene20(4): 484–9.(January 2001).doi:10.1038/sj.onc.1204113.PMID11313979.
“Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA”.Oncogene11(10): 1931–7.(November 1995).PMID7478510.
“Identification of a functional domain in a GADD45-mediated G2/M checkpoint”.J. Biol. Chem.275(47): 36892–8.(November 2000).doi:10.1074/jbc.M005319200.PMID10973963.
“A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth”.J. Biol. Chem.274(35): 24766–72.(August 1999).doi:10.1074/jbc.274.35.24766.PMID10455148.
“PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition”.Oncogene19(46): 5291–7.(November 2000).doi:10.1038/sj.onc.1203901.PMID11077446.
“UV-induced binding of ING1 to PCNA regulates the induction of apoptosis”.J. Cell Sci.114(Pt 19): 3455–62.(October 2001).doi:10.1242/jcs.114.19.3455.PMID11682605.
“Ku antigen, an origin-specific binding protein that associates with replication proteins, is required for mammalian DNA replication”.Biochim. Biophys. Acta1578(1–3): 59–72.(October 2002).doi:10.1016/s0167-4781(02)00497-9.PMID12393188.
“Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen”.J. Biol. Chem.275(50): 39458–65.(December 2000).doi:10.1074/jbc.M006626200.PMID10978339.
“Human homolog of the MutY repair protein (hMYH) physically interacts with proteins involved in long patch DNA base excision repair”.J. Biol. Chem.276(8): 5547–55.(February 2001).doi:10.1074/jbc.M008463200.PMID11092888.
“Direct interaction of proliferating cell nuclear antigen with the small subunit of DNA polymerase delta”.J. Biol. Chem.277(27): 24340–5.(July 2002).doi:10.1074/jbc.M200065200.PMID11986310.
“Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta”.J. Biol. Chem.276(52): 49258–66.(December 2001).doi:10.1074/jbc.M106990200.PMID11595739.
“Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen”.J. Biol. Chem.278(12): 10041–7.(March 2003).doi:10.1074/jbc.M208694200.PMID12522211.
“Human DNA polymerase lambda functionally and physically interacts with proliferating cell nuclear antigen in normal and translesion DNA synthesis”.J. Biol. Chem.277(50): 48434–40.(December 2002).doi:10.1074/jbc.M206889200.PMID12368291.
“Over-expression of human DNA polymerase lambda in E. coli and characterization of the recombinant enzyme”.Genes Cells7(7): 639–51.(July 2002).doi:10.1046/j.1365-2443.2002.00547.x.PMID12081642.
“Replication factor C interacts with the C-terminal side of proliferating cell nuclear antigen”.J. Biol. Chem.272(3): 1769–76.(January 1997).doi:10.1074/jbc.272.3.1769.PMID8999859.
“The DNA-binding subunit p140 of replication factor C is upregulated in cycling cells and associates with G1 phase cell cycle regulatory proteins”.J. Mol. Med.77(4): 386–92.(April 1999).doi:10.1007/s001090050365.PMID10353443.
“A complex consisting of human replication factor C p40, p37, and p36 subunits is a DNA-dependent ATPase and an intermediate in the assembly of the holoenzyme”.J. Biol. Chem.272(30): 18974–81.(July 1997).doi:10.1074/jbc.272.30.18974.PMID9228079.
“Cloning and characterization of hCTF18, hCTF8, and hDCC1. Human homologs of a Saccharomyces cerevisiae complex involved in sister chromatid cohesion establishment”.J. Biol. Chem.278(32): 30051–6.(August 2003).doi:10.1074/jbc.M211591200.PMID12766176.
“Characterisation of the interaction between WRN, the helicase/exonuclease defective in progeroid Werner's syndrome, and an essential replication factor, PCNA”.Mech. Ageing Dev.124(2): 167–74.(February 2003).doi:10.1016/s0047-6374(02)00131-8.PMID12633936.
“Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen”.Cancer Res.59(2): 342–6.(January 1999).PMID9927044.
“PCNA: a silent housekeeper or a potential therapeutic target?”.Trends in Pharmacological Sciences35(4): 178–186.(Apr 2014).doi:10.1016/j.tips.2014.02.004.PMID24655521.
“Improving responses in hepatomas with circadian-patterned hepatic artery infusions of recombinant interleukin-2”.J. Immunother.12(4): 219–223.(1993).doi:10.1097/00002371-199211000-00001.PMID1477073.
“Analysis of the proliferating cell nuclear antigen promoter and its response to adenovirus early region 1”.J. Biol. Chem.265(27): 16116–25.(1990).doi:10.1016/S0021-9258(17)46196-5.PMID1975809.
“Localization of the gene for human proliferating nuclear antigen/cyclin by in situ hybridization”.Hum. Genet.86(1): 84–6.(1991).doi:10.1007/bf00205180.PMID1979311.
“Human gene for proliferating cell nuclear antigen has pseudogenes and localizes to chromosome 20”.Somat. Cell Mol. Genet.15(4): 297–307.(1989).doi:10.1007/BF01534969.PMID2569765.
“Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA”.Oncogene11(10): 1931–7.(1995).PMID7478510.
“Lagging strand DNA synthesis at the eukaryotic replication fork involves binding and stimulation of FEN-1 by proliferating cell nuclear antigen”.J. Biol. Chem.270(38): 22109–12.(1995).doi:10.1074/jbc.270.38.22109.PMID7673186.
“Structure-function relationship of the eukaryotic DNA replication factor, proliferating cell nuclear antigen”.J. Biol. Chem.270(38): 22527–34.(1995).doi:10.1074/jbc.270.38.22527.PMID7673244.
“A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen”.Curr. Biol.5(3): 275–282.(1995).doi:10.1016/S0960-9822(95)00058-3.PMID7780738.
“Characterisation of the interaction between PCNA and Gadd45”.Oncogene10(12): 2427–33.(1995).PMID7784094.
“Association of proliferating cell nuclear antigen with cyclin-dependent kinases and cyclins in normal and transformed human T lymphocytes”.Blood84(10): 3413–21.(1994).doi:10.1182/blood.V84.10.3413.3413.PMID7949095.